Erick Wayne DeVinney
CIK: 0001595972
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Axogen, Inc.
Discretionary Trading P&L
Holdings
Transaction History (21 total)
- Mar 16, 2026AXGN
Axogen, Inc.
Exercise(M)Direct6.4K shares- - Mar 16, 2026AXGN
Axogen, Inc.
Sale(S)Direct5.2K shares at avg. $32.84$171K - Mar 16, 2026AXGN
Axogen, Inc.
Exercise(M)Direct11.6K shares- - Mar 16, 2026AXGN
Axogen, Inc.
Tax Payment(F)Direct2.9K shares at avg. $32.84$94K - Mar 1, 2026AXGN
Axogen, Inc.
Tax Payment(F)Direct11.3K shares at avg. $30.65$346K - Feb 26, 2026AXGN
Axogen, Inc.
Award(A)Direct33.8K shares- - Feb 26, 2026AXGN
Axogen, Inc.
Tax Payment(F)Direct10.7K shares at avg. $31.90$341K - Dec 9, 2025AXGN
Axogen, Inc.
Sale(S)Direct19.5K shares at avg. $31.21$609K - Dec 4, 2025AXGN
Axogen, Inc.
Award(A)Direct40K shares- - Sep 16, 2025AXGN
Axogen, Inc.
Sale(S)Direct1.1K shares at avg. $16.29$19K - Sep 13, 2025AXGN
Axogen, Inc.
Award(A)Direct2.5K shares- - Mar 25, 2025AXGN
Axogen, Inc.
Award(A)DirectRestricted Stock Units
38K shares- - Mar 19, 2025AXGN
Axogen, Inc.
Sale(S)Direct15.1K shares at avg. $17.50$264K - Mar 16, 2025AXGN
Axogen, Inc.
Exercise(M)Direct6.4K shares- - Mar 16, 2025AXGN
Axogen, Inc.
Exercise(M)Direct3K shares- - Mar 16, 2025AXGN
Axogen, Inc.
Exercise(M)Direct23.2K shares- - Mar 4, 2025AXGN
Axogen, Inc.
Tax Payment(F)Direct8.3K shares at avg. $18.35$152K - Feb 28, 2025AXGN
Axogen, Inc.
Exercise(M)Direct24.8K shares- - Feb 25, 2025AXGN
Axogen, Inc.
Tax Payment(F)Direct972 shares at avg. $16.50$16K - Feb 22, 2025AXGN
Axogen, Inc.
Award(A)Direct2.5K shares- - Sep 13, 2024AXGN
Axogen, Inc.
Award(A)Direct2.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 16, 2026 | AXGN Axogen, Inc. | Exercise(M) | 6,363 | - | $0 | Direct |
| Mar 16, 2026 | AXGN Axogen, Inc. | Sale(S) | 5,221 | $32.84 | $171,458 | Direct |
| Mar 16, 2026 | AXGN Axogen, Inc. | Exercise(M) | 11,575 | - | $0 | Direct |
| Mar 16, 2026 | AXGN Axogen, Inc. | Tax Payment(F) | 2,870 | $32.84 | $94,251 | Direct |
| Mar 1, 2026 | AXGN Axogen, Inc. | Tax Payment(F) | 11,276 | $30.65 | $345,609 | Direct |
| Feb 26, 2026 | AXGN Axogen, Inc. | Award(A) | 33,780 | - | $0 | Direct |
| Feb 26, 2026 | AXGN Axogen, Inc. | Tax Payment(F) | 10,702 | $31.90 | $341,394 | Direct |
| Dec 9, 2025 | AXGN Axogen, Inc. | Sale(S) | 19,517 | $31.21 | $609,087 | Direct |
| Dec 4, 2025 | AXGN Axogen, Inc. | Award(A) | 40,000 | - | - | Direct |
| Sep 16, 2025 | AXGN Axogen, Inc. | Sale(S) | 1,137 | $16.29 | $18,522 | Direct |
| Sep 13, 2025 | AXGN Axogen, Inc. | Award(A) | 2,500 | - | - | Direct |
| Mar 25, 2025 | AXGN Axogen, Inc. | Award(A) Restricted Stock Units | 38,000 | - | - | Direct |
| Mar 19, 2025 | AXGN Axogen, Inc. | Sale(S) | 15,111 | $17.50 | $264,443 | Direct |
| Mar 16, 2025 | AXGN Axogen, Inc. | Exercise(M) | 6,362 | - | - | Direct |
| Mar 16, 2025 | AXGN Axogen, Inc. | Exercise(M) | 2,950 | - | - | Direct |
| Mar 16, 2025 | AXGN Axogen, Inc. | Exercise(M) | 23,150 | - | - | Direct |
| Mar 4, 2025 | AXGN Axogen, Inc. | Tax Payment(F) | 8,296 | $18.35 | $152,232 | Direct |
| Feb 28, 2025 | AXGN Axogen, Inc. | Exercise(M) | 24,799 | - | - | Direct |
| Feb 25, 2025 | AXGN Axogen, Inc. | Tax Payment(F) | 972 | $16.50 | $16,038 | Direct |
| Feb 22, 2025 | AXGN Axogen, Inc. | Award(A) | 2,500 | - | - | Direct |
| Sep 13, 2024 | AXGN Axogen, Inc. | Award(A) | 2,500 | - | $0 | Direct |
1-21 of 21 transactions
About DeVinney Erick Wayne
DeVinney Erick Wayne (SEC CIK 0001595972) files insider reports with the SEC as Chief Innovation Officer of Axogen, Inc. (AXGN).
Signal8 holds 10 ownership filings by DeVinney Erick Wayne, all Form 4s, filed between Sep 13, 2024 and Mar 18, 2026. Those filings report 21 transactions, from Sep 13, 2024 to Mar 16, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on DeVinney Erick Wayne's filings is in ALACHUA, FL.
Recent filings by DeVinney Erick Wayne
- Mar 16, 2026: Option exercise of AXGN shares (Form 4, code M).
- Mar 16, 2026: Open-market sale of AXGN shares (Form 4, code S).
- Mar 16, 2026: Option exercise of AXGN shares (Form 4, code M).
- Mar 16, 2026: Tax withholding of AXGN shares (Form 4, code F).
- Mar 1, 2026: Tax withholding of AXGN shares (Form 4, code F).
Other insiders filing for Axogen, Inc. (AXGN)
- TYNDALL JOSEPH A., Director
- Began Marc A, EVP & General Counsel
- Wendell Amy McBride, Director
- Weiler Kathy Johnson, Director
- Burke William P. Mr., Director
- JOHNSON JOHN, Director